Olympus Corporation (OLYMY)
OTCMKTS · Delayed Price · Currency is USD
13.40
+0.40 (3.08%)
Oct 6, 2025, 9:30 AM EDT
Olympus Market Cap
Olympus has a market cap or net worth of $14.15 billion as of October 7, 2025. Its market cap has decreased by -30.64% in one year.
Market Cap
14.15B
Enterprise Value
14.39B
Revenue
6.72B
Ranking
n/a
PE Ratio
18.18
Stock Price
$13.40
Market Cap Chart
Since January 16, 1992, Olympus's market cap has increased from 2.39B to 14.15B, an increase of 491.23%. That is a compound annual growth rate of 5.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 14.15B | -16.82% |
| Dec 30, 2024 | 17.01B | -1.61% |
| Dec 29, 2023 | 17.29B | -23.63% |
| Dec 30, 2022 | 22.64B | -23.48% |
| Dec 30, 2021 | 29.58B | 5.35% |
| Dec 30, 2020 | 28.08B | 40.78% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 798.20M |
| Elite Pharmaceuticals | 686.89M |
| Glass House Brands | 644.95M |
| Northwest Biotherapeutics | 382.92M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 326.79M |
| American Oncology Network | 281.53M |
| Silence Therapeutics | 236.17M |